The QGCT® (Quantitative Gene Co-expression Test) is an RNA co-expression test that examines over 20,000 genes and their complete interactions to identify disease pathways and actionable drug targets specific to each patient's cancer.
BYQMed's AI-powered platform provides oncologists with comprehensive, data-driven insights to move beyond generic treatment protocols and toward truly personalized cancer care.
QGCT is a molecular analytics solution designed to examine tumor gene co-expression patterns and interaction networks from tissue-derived data, helping healthcare and research professionals generate deeper insights into cancer biology.
By analyzing more than 20,000 genes and their network relationships, QGCT supports interpretation of complex molecular profiles and enables more informed evaluation in precision oncology and translational research settings.
No results match your search. Try removing a few filters.
